| Title: | Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine |
| Author: | Greilsamer, Glenn J. |
| Citation: | Aiding AIDS: Hurdling the Obstacles to the Development of an Effective AIDS Vaccine (2002 Third Year Paper) |
| Full Text & Related Files: |
greilsamer.pdf (573bytes; PDF)
greilsamer.rtf (303.8Kb; RTF file)
greilsamer.html (233.7Kb; HTML)
|
| Abstract: | This paper explores the various impediments to the development of a safe and effective AIDS vaccine, and offers suggestions to help overcome these obstacles. I begin by discussing the FDA approval process and the current state of AIDS vaccine development. I then consider the different scientific impediments to the development of a preventive vaccine. The next section addresses the logistical and ethical issues in the clinical testing of a vaccine. I discuss the ethical principles that should guide researchers, demonstrate the social harm that participation may cause volunteers, and suggest methods to resolve these ethical dilemmas. Finally, I discuss the economic impediments faced by manufacturers in the form of high costs, uncertain profit margins, and unpredictable liability. Using past legislative attempts at restructuring manufacturer incentives as models, I present recommendations to help encourage manufacturers to produce the safest and most effective vaccine they can, and make it available as quickly as possible. |
| Terms of Use: | This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA |
| Citable link to this page: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852124 |
Contact administrator regarding this item (to report mistakes or request changes)